Free Trial
ASX:VP7

Dealt (VP7) Stock Price, News & Analysis

Dealt logo

About Dealt Stock (ASX:VP7)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VP7 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dealt and its competitors with MarketBeat's FREE daily newsletter.

VP7 Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Facebook's digital currency dealt another blow
See More Headlines

VP7 Stock Analysis - Frequently Asked Questions

Dealt Limited (ASX:VP7) issued its quarterly earnings data on Tuesday, February, 26th. The company reported $0.00 EPS for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Dealt investors own include Aurinia Pharmaceuticals (AUPH), Athenex (ATNX), Ascendis Pharma A/S (ASND), Ardelyx (ARDX), Arcturus Therapeutics (ARCT), Aptose Biosciences (APTO) and Fresh2 Group (ANPC).

Company Calendar

Last Earnings
2/26/2019
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Real Estate - General
Sub-Industry
N/A
Current Symbol
ASX:VP7
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
408.29
Current Ratio
1.95
Quick Ratio
0.20

Sales & Book Value

Annual Sales
A$53.91 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
1.53
Book Value
A$0.56 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
11,389,900
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (ASX:VP7) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners